Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
THE WOODLANDS, Texas, Sept. 22, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 20, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 4:00 p.m., Eastern time, on September 25, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. The Company has decided to adjourn the Special M
THE WOODLANDS, Texas, Sept. 14, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 13, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 10:00 a.m., Eastern time, on September 20, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. As previously announced, the Company has recei
THE WOODLANDS, Texas, Sept. 11, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 8, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 4:00 p.m., Eastern time, on September 13, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. As previously announced, the Company has receive
SC 13G - NKGen Biotech, Inc. (0001845459) (Subject)
SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)
SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)